TR201818986A2 - İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar - Google Patents

İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar

Info

Publication number
TR201818986A2
TR201818986A2 TR2018/18986A TR201818986A TR201818986A2 TR 201818986 A2 TR201818986 A2 TR 201818986A2 TR 2018/18986 A TR2018/18986 A TR 2018/18986A TR 201818986 A TR201818986 A TR 201818986A TR 201818986 A2 TR201818986 A2 TR 201818986A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
ivabradin
metoprolol
oral pharmaceutical
compositions containing
Prior art date
Application number
TR2018/18986A
Other languages
English (en)
Inventor
Güner Di̇cle
Palantöken Arzu
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2018/18986A priority Critical patent/TR201818986A2/tr
Publication of TR201818986A2 publication Critical patent/TR201818986A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, ivabradin veya ivabradin oral farmasötik kompozisyonlarla ilgilidir.
TR2018/18986A 2018-12-10 2018-12-10 İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar TR201818986A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2018/18986A TR201818986A2 (tr) 2018-12-10 2018-12-10 İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2018/18986A TR201818986A2 (tr) 2018-12-10 2018-12-10 İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar

Publications (1)

Publication Number Publication Date
TR201818986A2 true TR201818986A2 (tr) 2020-06-22

Family

ID=76328232

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/18986A TR201818986A2 (tr) 2018-12-10 2018-12-10 İvabradi̇n ve metoprolol i̇çeren kati oral farmasöti̇k kompozi̇syonlar

Country Status (1)

Country Link
TR (1) TR201818986A2 (tr)

Similar Documents

Publication Publication Date Title
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
MX2025001902A (es) Construcciones de anticuerpos anti-ror
CY1123194T1 (el) Νεες αντιβακτηριακες ενωσεις
CY1124425T1 (el) Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
EA201992177A1 (ru) Композиции на основе нирапариба
PH12017502255B1 (en) Nrf2 regulators
JOP20210305A1 (ar) صيغ إيماتينيب وتصنيعها واستخداماتها
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
PH12018502714A1 (en) Nicotine particles and compositions
EP4112611A3 (en) Modulators of sestrin-gator2 interaction and uses thereof
EP3463277A4 (en) FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS THEREFOR AND USES THEREOF
MX2022007959A (es) Nuevos anticuerpos anti-fgfr2b.
MX2022007961A (es) Nuevos anticuerpos anti-fgfr2b.
CY1123465T1 (el) Αντιβακτηριακες ενωσεις ευρεως φασματος
MX2025009320A (es) Anticuerpos anti-cd19 novedosos
MX367669B (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos.
MX2019002057A (es) Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc.
MX2022007960A (es) Nuevos anticuerpos anti-fgfr2b.
EA201792262A1 (ru) Пироглутамат вортиоксетина
MX2020005483A (es) Antagonistas de ildr2 y combinaciones de los mismos.
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
WO2019203755A3 (en) A solid oral dosage form comprising linagliptin
MX376853B (es) Odorante osmanthus.
MX2020006292A (es) Complejos de carbamato de aminoacidos.
TR201914406A2 (tr) Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar